US interceptor stocks flagged as inadequate for high-intensity China fight

Key facts

• Heritage Foundation claims the US would exhaust key interceptors “within days” in a China conflict and holds under 10% of required PAC-3 MSE, THAAD, SM-6 and SM-3 quantities.
• Heritage cites ~1,738 theatre surface-to-air munitions expended in the first four days of “Operation Epic Fury” against 565 ballistic missiles and 57 cruise missiles.
• US plans include tripling PAC-3 output from 600 to 2,000 per year and a $3bn Northrop/Lockheed/DoD agreement to expand solid rocket motors and “quadruple” THAAD output over seven years.

3 minute read

The Defense One report, citing a new Heritage Foundation assessment, frames US theatre missile-defence interceptor inventories as a near-term limiting factor in any high-intensity Pacific conflict. Heritage’s core judgement is that the United States would run out of the interceptors needed to defeat Chinese missiles “within days” and that current holdings amount to less than 10% of what would be required to deter or prevail in a protracted conflict, explicitly naming PAC-3 MSE, THAAD, SM-6 and SM-3 as the critical categories.

This argument is positioned as a continuation—and sharpening—of prior CSIS work. A 2023 CSIS analysis assessed that inventories of PAC-3 MSE, THAAD and Standard Missile variants would be depleted “within the first week” of a Taiwan conflict. A May follow-on concluded that replenishment would take years, producing a sustained “window of vulnerability” until stocks return to prior levels and then reach the higher quantities desired by war planners.

Industrial and acquisition measures described in the source point to acceleration but also to a moving target. The White House established a framework in January intended to triple PAC-3 production from 600 to 2,000 per year, while a $3bn agreement announced this week between Northrop Grumman, Lockheed Martin and the Department of Defense aims to expand solid rocket motor supply for PAC-3 and to “quadruple” THAAD interceptor output over seven years. However, CSIS’s Tom Karako is quoted arguing that production metrics set before “Operation Epic Fury” are no longer commensurate with expenditure, implying that real-world combat consumption has effectively “spent” years of planned output in a short period.

Heritage’s expenditure figures from the Iran operation serve as the article’s key datapoint for depletion dynamics: approximately 1,738 theatre surface-to-air munitions used in four days against 565 Iranian ballistic missiles and 57 cruise missiles. The piece also highlights a compounding demand driver that is directly relevant to the drone domain: the Heritage report is described as potentially understating the challenge because it does not fully account for how China could use low-cost drones to saturate defences, a concern echoed by INDOPACOM commander Adm. Sam Paparo’s testimony that production timelines are misaligned with operational expenditure and that the US lacks adequate solutions against cheap drones.

For Europe, the implications are immediate and structural. First, any Pacific surge in US interceptor demand risks tightening availability for European contingencies, particularly for Patriot-class interceptors already central to NATO’s integrated air and missile defence and to Ukraine support. Second, the report underscores that magazine depth, motor supply, and seeker/warhead production are not abstract capacity issues but determinants of deterrence credibility—driving European procurement toward larger war reserves, multi-year contracts, and co-production/licensing arrangements. The mention of Ukraine exploring PAC-3 licensing with Lockheed Martin—yet with deliveries not expected until 2030—illustrates that “sovereign” missile production timelines are long and must be initiated early to have deterrent value within this decade.

Source: Defense One